4-(((4-((4-chlorphenyl)amino)furo(2,3-d)pyridazin-7-yl)oxy)methyl)-N-methylpyridine-2-carboxamide,
BAY 57-9352,
telatinib,
Telatinib,
332012-40-5,
Bay 57-9352,
Telatinib (BAY 57-9352),
UNII-18P7197Q7J,
BAY57-9352,
CHEMBL2079588,
4-[[4-(4-Chloroanilino)furo[2,3-d]pyridazin-7-yl]oxymethyl]-N-methyl-pyridine-2-carboxamide,
18P7197Q7J,
BAY-579352,
4-((4-(4-chlorophenylamino)furo[2,3-d]pyridazin-7-yloxy)methyl)-N-methylpicolinamide,
4-[[4-(4-chloroanilino)furo[2,3-d]pyridazin-7-yl]oxymethyl]-N-methylpyridine-2-carboxamide,
Telatinib [INN],
BAY-57-9352,
JSPY-st000264,
MLS006010950,
Telatinib-BAY-57-9352,
SCHEMBL1250560,
Bay 57-9352 (Telatinib),
KS-00001CRQ,
Telatinib - BAY 57-9352,
EX-A007,
QCR-162,
BCPP000050,
HMS3655F14,
ZINC590964,
BCP02409,
ABP000891,
BDBM50399538,
MFCD18251453,
s2231,
AKOS015909525,
BAY 579352,
CS-3722,
EX-8672,
PB30302,
RL03209,
SB13250,
NCGC00249392-01,
2-Pyridinecarboxamide, 4-(((4-((4-chlorophenyl)amino)furo(2,3-d)pyridazin-7-yl)oxy)methyl)-N-methyl-,
4CA-1222,
AC-25239,
BC638771,
HY-10527,
SMR004702754,
AB0033773,
FT-0674832,
SW220176-1,
Telatinib(BAY57-9352)/BAY57-9352,
X7508,
A25614,
J-524317,
I14-31864,
BAY 57-9352, 332012-40-5,
4-(((4-((4-chlorophenyl)amino)furo[2,3-d]pyridazin-7-yl)oxy)methyl)-N-methylpicolinamide,
2-Pyridinecarboxamide,4-[[[4-[(4-chlorophenyl)amino]furo[2,3-d]pyridazin-7-yl]oxy]methyl]-N-methyl-,
D07NOI,
C20H16ClN5O3,
cc-418,
CID9808844,
CID 9808844,
A8550,
A10903,
4-[[[4-[(4-Chlorophenyl)amino]furo[2,3-d]pyridazin-7-yl]oxy]methyl]-N-methyl-2-pyridinecarboxamide,
75747-14-7,